Samjin Pharm’s Q2 earnings rose 7.46% on-year

[DISCLOSURE] Samjin Pharm (005500) said on July 26 that its second-quarter operating profit rose 7.46 percent on-year to 10.8 billion won (US$9.46 million).

Sales increased 11.84 percent to 60.9 billion won, while net profit reached 8.3 billion won after rising 16 percent.